Hymovis® HYADD4 represents an advanced approach to hyaluronic acid–based viscosupplementation. Developed using proprietary HYADD®4 technology, the formulation combines structural characteristics of both low- and high-molecular-weight hyaluronic acid in a single modified molecule, aiming to optimise viscoelastic performance while maintaining favourable biocompatibility.
The patented HYADD®4 molecule provides enhanced rheological properties, allowing the product to remain longer within the joint space and support physiological joint function. Hymovis has been certified in Europe for conservative intra-articular management of degenerative meniscal lesions and is widely used in the context of osteoarthritic joint conditions.
Key characteristics of the HYADD®4 technology include:
- optimised viscoelasticity for joint lubrication and shock absorption;
- prolonged intra-articular residence time;
- favourable interaction with synovial tissues;
- high tolerability profile.
When administered intra-articularly by a qualified medical professional, Hymovis® supports joint homeostasis and may contribute to:
- reduction of joint discomfort associated with degenerative changes;
- improvement of joint mobility and functional performance;
- reduction of joint stiffness;
- mechanical protection of articular cartilage;
- support of cartilage matrix metabolism.
Clinical use has shown sustained functional support over extended periods following treatment, depending on individual patient factors and clinical indications.
Hymovis® is intended for intra-articular use in joints affected by degenerative conditions, including:
- osteoarthritis of the knee;
- shoulder, hip, ankle and thumb joints;
- degenerative meniscal lesions (as a conservative treatment option).
Recommended Use
Treatment protocols are determined by the treating physician based on clinical assessment. A commonly used regimen consists of two intra-articular injections, administered according to professional guidelines and indication-specific requirements.
Active substance:
- Modified hyaluronic acid — HYADD®4
Package contents:
- 2 prefilled sterile syringes, each containing 3.0 ml
- Ready for intra-articular administration
Important Notice
This product is intended exclusively for professional medical use.
Administration must be performed by a qualified healthcare professional trained in intra-articular injection techniques.
Not intended for self-administration.